 | ||||||
| "anti diabetes" | ||||||
| WEB | ||||||
| J&J attracts Chinese interest for its diabetes business in a potential $3B to $4B deal Generis has presence across anti-infective, respiratory, anti-diabetes and dermatology drugs, besides a contract manufacturing and analytical services arm. It generated sales of around $60 million last year. Aurobindo's latest bid comes on the heels of last month's shot at Israeli drug maker Teva's UK ...
| ||||||
| You have received this email because you have subscribed to Google Alerts. |
 Receive this alert as RSS feed |
| Send Feedback |
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.